Do not take ALA (alpha-lipoic acid) for migraines- at least for now.

Do not take ALA (alpha-lipoic acid) for migraines- at least for now.

Cerebral Torque

Alpha-Lipoic Acid or ALA is most commonly known for its use in patients with diabetic neuropathy.

In the most recent study evaluating ALA for migraines, it was found that "no significant changes were observed for NO levels and duration of migraine pains."

Moreover, ALA was found to reduce the lifespan of mice.

https://pubmed.ncbi.nlm.nih.gov/22785389/

Healthy mice treated long-term with ALA developed hepatic steatosis and liver injury. The effect of long-term ALA supplementation in humans is currently unknown and, therefore, it is possible that similar negative effects could be observed.

With the risk of shortening lifespan and causing injury, ALA is just not worth the risk especially with limited to no benefit. 
Back to blog
  • A Breakthrough on the Horizon: PACAP-Targeting Antibodies Offer New Promise for Migraine Prevention

    A Breakthrough on the Horizon: PACAP-Targeting ...

    Cerebral Torque

    Migraine patients may soon have a new treatment option. Recent clinical trials show promising results for Lu AG09222, a monoclonal antibody targeting PACAP, a neuropeptide involved in migraine pathophysiology.

    A Breakthrough on the Horizon: PACAP-Targeting ...

    Cerebral Torque

    Migraine patients may soon have a new treatment option. Recent clinical trials show promising results for Lu AG09222, a monoclonal antibody targeting PACAP, a neuropeptide involved in migraine pathophysiology.

  • New Study Maps Migraine Symptoms Across Attack Phases

    New Study Maps Migraine Symptoms Across Attack ...

    Cerebral Torque

    Symptom Pre-headache* Headache* Post-headache* Interictal* Pooled %** Notes Head pain 50% 100% 28% 5% 100% Only universally reported symptom; defining feature of headache phase Light sensitivity 75% 80% 30% 13%...

    New Study Maps Migraine Symptoms Across Attack ...

    Cerebral Torque

    Symptom Pre-headache* Headache* Post-headache* Interictal* Pooled %** Notes Head pain 50% 100% 28% 5% 100% Only universally reported symptom; defining feature of headache phase Light sensitivity 75% 80% 30% 13%...

  • White Matter Lesions in Migraine Patients: What You Need to Know

    White Matter Lesions in Migraine Patients: What...

    Cerebral Torque

    Discover what white matter lesions mean for migraine patients. This guide explores the latest research on the relationship between migraine and brain changes, offering insights into prevalence, potential causes, and...

    White Matter Lesions in Migraine Patients: What...

    Cerebral Torque

    Discover what white matter lesions mean for migraine patients. This guide explores the latest research on the relationship between migraine and brain changes, offering insights into prevalence, potential causes, and...

  • Gepant Adverse Events Chart

    Gepant Adverse Events Chart

    Cerebral Torque

    A comprehensive analysis of real-world data has uncovered important insights into the safety profiles of gepant medications used for migraine treatment. The study, which examined adverse events reported in the...

    Gepant Adverse Events Chart

    Cerebral Torque

    A comprehensive analysis of real-world data has uncovered important insights into the safety profiles of gepant medications used for migraine treatment. The study, which examined adverse events reported in the...

1 4
View all